SB
Samsara BioCapital’s Janux Therapeutics JANX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,263
| Closed | -$603K | – | 41 |
|
|
2024
Q4 | $603K | Sell |
11,263
-11,263
| -50% | -$603K | 0.08% | 36 |
|
|
2024
Q3 | $1.02M | Sell |
22,526
-22,526
| -50% | -$1.02M | 0.2% | 32 |
|
|
2024
Q2 | $1.89M | Sell |
45,052
-135,155
| -75% | -$5.66M | 0.4% | 29 |
|
|
2024
Q1 | $6.78M | Sell |
180,207
-180,207
| -50% | -$6.78M | 1.05% | 20 |
|
|
2023
Q4 | $3.87M | Hold |
360,414
| – | – | 0.6% | 25 |
|
|
2023
Q3 | $3.63M | Hold |
360,414
| – | – | 1.11% | 24 |
|
|
2023
Q2 | $4.28M | Hold |
360,414
| – | – | 0.75% | 23 |
|
|
2023
Q1 | $4.36M | Hold |
360,414
| – | – | 0.9% | 22 |
|
|
2022
Q4 | $4.75M | Hold |
360,414
| – | – | 1.02% | 20 |
|
|
2022
Q3 | $4.88M | Hold |
360,414
| – | – | 1.14% | 23 |
|
|
2022
Q2 | $4.4M | Sell |
360,414
-51,457
| -12% | -$628K | 1.17% | 22 |
|
|
2022
Q1 | $5.91M | Hold |
411,871
| – | – | 1.49% | 15 |
|
|
2021
Q4 | $8.13M | Hold |
411,871
| – | – | 1.58% | 15 |
|
|
2021
Q3 | $8.91M | Sell |
411,871
-196,078
| -32% | -$4.24M | 1.4% | 17 |
|
|
2021
Q2 | $15.2M | Buy |
+607,949
| New | +$15.2M | 1.87% | 10 |
|